发明名称 Inhibitors of dipeptidyl peptidase IV
摘要 Compounds according to general formula (1), wherein R<SUP>1 </SUP>is H or CN, X<SUP>1 </SUP>is S, O, SO<SUB>2 </SUB>or CH<SUB>2</SUB>, X<SUP>2 </SUP>is O, S or CH<SUB>2</SUB>, X<SUP>3 </SUP>is NR<SUP>5 </SUP>or a carbonyl or thiocarbonyl group and R<SUP>4 </SUP>is R<SUP>6</SUP>R<SUP>7</SUP>N, R<SUP>8</SUP>(CH<SUB>2</SUB>)<SUB>q</SUB>OC(-O), R<SUP>8</SUP>(CH<SUB>2</SUB>)<SUB>q</SUB>OC(-S), R<SUP>6</SUP>R<SUP>7</SUP>NC(-O), R<SUP>6</SUP>R<SUP>7</SUP>NC(-S); R<SUP>8</SUP>(CH<SUB>2</SUB>)<SUB>q</SUB>C(-O), R<SUP>8</SUP>(CH<SUB>2</SUB>)<SUB>q</SUB>C(-S) or R<SUP>8</SUP>(CH<SUB>2</SUB>)<SUB>q</SUB>SO<SUB>2</SUB>, m is 1-3 and n is 0-4 are new. The compounds of the invention are inhibitors of dipeptidyl peptidase IV. Pharmaceutical compositions of the compounds of the invention, or pharmaceutically acceptable salts thereof, are useful in the treatment of, inter alia, type 2 diabetes
申请公布号 US7189728(B2) 申请公布日期 2007.03.13
申请号 US20030221129 申请日期 2003.01.09
申请人 FERRING, BV 发明人 EVANS DAVID MICHAEL;PITT GARY ROBERT WILLIAM
分类号 C07D295/18;A01N43/36;A01N43/40;A61K31/40;A61K31/4025;A61K31/4178;A61K31/422;A61K31/426;A61K31/427;A61K31/437;A61K31/44;A61K31/4439;A61K31/454;A61K31/4709;A61K31/4725;A61K31/496;A61K31/497;A61K31/498;A61K31/506;A61K31/5377;A61P3/10;A61P5/06;A61P5/50;A61P15/00;A61P15/08;A61P29/00;A61P37/02;A61P43/00;C07D207/16;C07D213/74;C07D213/82;C07D217/06;C07D217/26;C07D233/84;C07D241/24;C07D277/04;C07D295/185;C07D401/12;C07D403/12;C07D405/12;C07D409/12;C07D413/12;C07D417/08;C07D417/12;C07D417/14;C07D471/04 主分类号 C07D295/18
代理机构 代理人
主权项
地址